BioLargo (NASDAQ:BLGO – Get Free Report) and Hawkins (NASDAQ:HWKN – Get Free Report) are both construction companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.
Earnings and Valuation
This table compares BioLargo and Hawkins”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BioLargo | $12.23 million | 4.92 | -$3.50 million | ($0.02) | -10.00 |
Hawkins | $919.16 million | 2.81 | $75.36 million | $3.91 | 31.55 |
Hawkins has higher revenue and earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than Hawkins, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Insider and Institutional Ownership
0.0% of BioLargo shares are held by institutional investors. Comparatively, 69.7% of Hawkins shares are held by institutional investors. 20.3% of BioLargo shares are held by company insiders. Comparatively, 3.8% of Hawkins shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares BioLargo and Hawkins’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BioLargo | -16.53% | -58.35% | -32.12% |
Hawkins | 8.74% | 19.64% | 12.13% |
Analyst Ratings
This is a summary of recent recommendations and price targets for BioLargo and Hawkins, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BioLargo | 0 | 0 | 0 | 0 | 0.00 |
Hawkins | 0 | 1 | 0 | 0 | 2.00 |
Hawkins has a consensus target price of $122.00, suggesting a potential downside of 1.12%. Given Hawkins’ stronger consensus rating and higher probable upside, analysts clearly believe Hawkins is more favorable than BioLargo.
Summary
Hawkins beats BioLargo on 11 of the 13 factors compared between the two stocks.
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
About Hawkins
Hawkins, Inc. operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products, such as liquid phosphates, lactates, other blended products, and agricultural products; and receives, stores, and distributes various chemicals comprising liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. The Water Treatment segment provides chemicals, products, equipment, services, and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, vitamins and amino acids, excipients, joint products, botanicals and herbs, sweeteners, and enzymes. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.
Receive News & Ratings for BioLargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLargo and related companies with MarketBeat.com's FREE daily email newsletter.